Clinical profile and treatment outcomes of metastatic neuroendocrine carcinoma: A single institution experience

BACKGROUND: Neuroendocrine carcinoma (NEC) is a rare tumor arising from the diffuse neuroendocrine system. Most of these present in the advanced stage and palliative chemotherapy remains the only option. The prognosis remains poor with the standard chemotherapy regimen of platinum and etoposide (EP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokesh, K. N., Anand, Abhishek, Lakshmaiah, K. C., Babu, K. Govind, Lokanatha, Dasappa, Jacob, Linu Abraham, Babu, M. C. Suresh, Rudresha, A. H., Rajeev, L. K., Saldanha, Smitha C., Giri, G. V., Panwar, Dipti, Koppaka, Deepak, Patidar, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
ORIGINAL ARTICLE: Neuroendocrine Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069343/
https://www.ncbi.nlm.nih.gov/pubmed/30112343
http://dx.doi.org/10.4103/sajc.sajc_176_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069343/
https://www.ncbi.nlm.nih.gov/pubmed/30112343
http://dx.doi.org/10.4103/sajc.sajc_176_17

Ejemplares similares